Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baccarani

Showing results (161-170 of 381) with videos related to

Pageof 39
Sort By:
Leukemia & Lymphoma|February 1, 1995
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomasF Silvestri, M Velisig, R Fanin, et al.
Haematologica|July 1, 1994
Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferonsF Silvestri, L Virgolini, A Mazzolini, et al.
British Journal of Haematology|February 1, 1997
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomasF Silvestri, G Barillari, R Fanin, et al.
Journal of Submicroscopic Cytology|July 1, 1983
A morphometric and ultrastructural study of the long term effect of portacaval anastomosis on the liver of normal male ratsI Pasquali Ronchetti, M Baccarani Contri, S Pittaluga, et al.
Haematologica|January 1, 1970
[Sprue syndrome and malignant lymphoma. 1 case]S Tura, G Martinelli, P R Dal Monte, et al.
Acta Haematologica|January 1, 1985
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosisM Cavo, P Galieni, M Gobbi, et al.
Vox Sanguinis|January 1, 1995
Laparoscopic splenectomy in idiopathic thrombocytopenic purpuraF Silvestri, L Virgolini, D Russo, et al.
Haematologica|May 1, 1996
Plasma cell P170 expression and response to treatment in multiple myelomaF Patriarca, C Melli, D Damiani, et al.
Haematologica|March 1, 1994
p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivativesM Michieli, D Damiani, A Michelutti, et al.
Leukemia & Lymphoma|February 1, 1993
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivativesM Michieli, A Michelutti, D Damiani, et al.
Pageof 39

Showing results (161-170 of 381) with videos related to

Sort By:
Pageof 39
Leukemia & Lymphoma|February 1, 1995
Granulocyte colony-stimulating factor (G-CSF) allows the delivery of effective doses of CHOP and CVP regimens in non-Hodgkin lymphomasF Silvestri, M Velisig, R Fanin, et al.
Haematologica|July 1, 1994
Development of autoimmune thyroid diseases during long-term treatment of hematological malignancies with alpha-interferonsF Silvestri, L Virgolini, A Mazzolini, et al.
British Journal of Haematology|February 1, 1997
Hepatitis C virus infection (and additional neoplasms) among marginal zone lymphomasF Silvestri, G Barillari, R Fanin, et al.
Journal of Submicroscopic Cytology|July 1, 1983
A morphometric and ultrastructural study of the long term effect of portacaval anastomosis on the liver of normal male ratsI Pasquali Ronchetti, M Baccarani Contri, S Pittaluga, et al.
Haematologica|January 1, 1970
[Sprue syndrome and malignant lymphoma. 1 case]S Tura, G Martinelli, P R Dal Monte, et al.
Acta Haematologica|January 1, 1985
Nonsecretory multiple myeloma. Presenting findings, clinical course and prognosisM Cavo, P Galieni, M Gobbi, et al.
Vox Sanguinis|January 1, 1995
Laparoscopic splenectomy in idiopathic thrombocytopenic purpuraF Silvestri, L Virgolini, D Russo, et al.
Haematologica|May 1, 1996
Plasma cell P170 expression and response to treatment in multiple myelomaF Patriarca, C Melli, D Damiani, et al.
Haematologica|March 1, 1994
p170-dependent multidrug resistance. Restoring full sensitivity to idarubicin with verapamil and cyclosporin A derivativesM Michieli, D Damiani, A Michelutti, et al.
Leukemia & Lymphoma|February 1, 1993
A comparative analysis of the sensitivity of multidrug resistant (MDR) and non-MDR cells to different anthracycline derivativesM Michieli, A Michelutti, D Damiani, et al.
Pageof 39